SCHEMBL29567371

SCHEMBL29567371

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2ccc(C3CCN(C)CC3)cc2)c1OC(C)C

nearest known ligand 0.35

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 6/20 0.35
▸ HTR7 P34969 6/20 0.35
▸ DRD2 P14416 1/20 0.34
▸ HTR6 P50406 1/20 0.34
▸ ALK Q9UM73 9/20 0.34
▸ INSR P06213 7/20 0.33
▸ KCNH2 Q12809 3/20 0.33
▸ SLC8A1 P32418 1/20 0.33
▸ BRD4 O60885 2/20 0.33
▸ JAK2 O60674 2/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ PTK2 Q05397 1/20 0.32
▸ NPM1 P06748 4/20 0.32
▸ EGFR P00533 1/20 0.32
▸ CYP3A4 P08684 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309894 1.00 HTR1A (0.35) HTR1AHTR7DRD2HTR6ALK
SCHEMBL26808714 0.92 HTR1A (0.36) HTR1AHTR7DRD2HTR6KCNH2
SCHEMBL26808698 0.90 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24309436 0.90 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24309783 0.90 HTR1A (0.37) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL29567061 0.90 HTR1A (0.37) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24309924 0.89 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL29566959 0.89 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL29566432 0.89 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1
SCHEMBL24310732 0.89 HTR1A (0.36) HTR1AHTR7DRD2HTR6SLC8A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback